Anika Therapeutics
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
4/10
|
43 | 48.77 | -11.83% | 25.09 | 71.37% |
| P/S |
|
2.05 | 33.76 | -93.93% |
|
|
| P/BV |
|
1.61 | 4.82 | -66.63% |
|
|
| P/FCF |
|
-38.14 | 60.98 | -162.55% |
|
|
| Ev/Ebitda |
|
-26.54 | -22.12 | 19.98% |
|
|
| Ev/S |
|
1.79 | 22.56 | -92.08% |
|
|
| Ev/FCF |
|
-41.25 | 68.75 | -160.01% |
|
|
| E/P |
|
-0.3004 | 0.0178 | -1790.14% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6.73 | 4.83 | -239.31% | 2.26 | -398.38% |
| ROE |
|
-38.95 | 9.61 | -505.42% |
|
|
| ROA |
|
-30.55 | 0.3359 | -9193.6% |
|
|
| ROIC |
|
-0.54 | 7.63 | -107.07% |
|
|
| ROS |
|
-49.6 | -25.17 | 97.06% |
|
|
| ROCE |
|
-11.99 | 15.33 | -178.2% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2.59 | -3.67 | -29.37% | -2.34 | 10.82% |
| Nеt Debt/Ebitda |
|
3.91 | -3.44 | -213.64% |
|
|
| Debt/Ratio |
|
0.1073 | 0.1972 | -45.58% |
|
|
| Debt/Equity |
|
0.6012 | 1.65 | -63.49% |
|
|
| Debt/Net Income |
|
-0.3513 | 10.31 | -103.41% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
304097.35 | 43.56 | 697940.29% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
6/10
|
44.92 | -56.89 | -178.96% |
| Growth impulse Ebitda 5 years |
|
-128.04 | -64.81 | 97.56% |
| Growth impulse Net Income 5 years |
|
-406.17 | -58.33 | 596.33% |
| Growth impulse FCF 5 years |
|
-121.22 | -47 | 157.91% |
| Growth impulse EPS 5 years |
|
-398.44 | -32.41 | 1129.37% |
IP Score
2.82/10
